Teleflex Incorporated (TFX)
NYSE: TFX · Real-Time Price · USD
120.50
+1.64 (1.38%)
Dec 5, 2025, 4:00 PM EST - Market closed
Teleflex Revenue
Teleflex had revenue of $913.02M in the quarter ending September 28, 2025, with 19.45% growth. This brings the company's revenue in the last twelve months to $3.19B, up 5.43% year-over-year. In the year 2024, Teleflex had annual revenue of $3.05B with 2.45% growth.
Revenue (ttm)
$3.19B
Revenue Growth
+5.43%
P/S Ratio
1.71
Revenue / Employee
$226,240
Employees
14,100
Market Cap
5.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.05B | 72.84M | 2.45% |
| Dec 31, 2023 | 2.97B | 183.45M | 6.57% |
| Dec 31, 2022 | 2.79B | -18.52M | -0.66% |
| Dec 31, 2021 | 2.81B | 272.41M | 10.74% |
| Dec 31, 2020 | 2.54B | -58.21M | -2.24% |
| Dec 31, 2019 | 2.60B | 146.98M | 6.00% |
| Dec 31, 2018 | 2.45B | 302.08M | 14.07% |
| Dec 31, 2017 | 2.15B | 278.28M | 14.90% |
| Dec 31, 2016 | 1.87B | 58.34M | 3.22% |
| Dec 31, 2015 | 1.81B | -30.14M | -1.64% |
| Dec 31, 2014 | 1.84B | 143.56M | 8.46% |
| Dec 31, 2013 | 1.70B | 145.26M | 9.37% |
| Dec 31, 2012 | 1.55B | 58.48M | 3.92% |
| Dec 31, 2011 | 1.49B | 94.81M | 6.78% |
| Dec 31, 2010 | 1.40B | -37.16M | -2.59% |
| Dec 31, 2009 | 1.43B | -477.20M | -24.96% |
| Dec 31, 2008 | 1.91B | 337.00M | 21.40% |
| Dec 31, 2007 | 1.58B | -115.73M | -6.84% |
| Dec 31, 2006 | 1.69B | 128.94M | 8.26% |
| Dec 25, 2005 | 1.56B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TFX News
- 18 days ago - Teleflex Incorporated (TFX) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 22 days ago - Teleflex Incorporated (TFX) Discusses Strategic Rationale and Portfolio Overview of Acquired Vascular Intervention Business Transcript - Seeking Alpha
- 22 days ago - Teleflex to Present at the Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 4 weeks ago - These Analysts Cut Their Forecasts On Teleflex Following Q3 Results - Benzinga
- 4 weeks ago - Teleflex Incorporated (TFX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Teleflex Announces Quarterly Dividend - GlobeNewsWire
- 4 weeks ago - Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook - GlobeNewsWire
- 7 weeks ago - Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details - GlobeNewsWire